Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota
Sozaburo Ihara, Yoshihiro Hirata, Kazuhiko Koike
Journal of Gastroenterology (2017) Vol. 52, Iss. 7, pp. 777-787
Open Access | Times Cited: 248

Showing 1-25 of 248 citing articles:

Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle, Joan Massagué
Immunity (2019) Vol. 50, Iss. 4, pp. 924-940
Open Access | Times Cited: 1762
TGF-β signaling in health and disease
Joan Massagué, Dean Sheppard
Cell (2023) Vol. 186, Iss. 19, pp. 4007-4037
Open Access | Times Cited: 315
Butyrate producers, “The Sentinel of Gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics
Vineet Singh, GyuDae Lee, HyunWoo Son, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 244
Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity
Amelia T. Soderholm, Virginia A. Pedicord
Immunology (2019) Vol. 158, Iss. 4, pp. 267-280
Open Access | Times Cited: 208
Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment
Yoshiro Itatani, Kenji Kawada, Yoshiharu Sakai
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5822-5822
Open Access | Times Cited: 203
Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells
Camille Martin‐Gallausiaux, Fabienne Béguet-Crespel, Ludovica Marinelli, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 179
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Urszula Cytlak, Douglas P. Dyer, Jamie Honeychurch, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 124-138
Open Access | Times Cited: 160
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
Eduardo J. Villablanca, Katja Selin, Charlotte Hedin
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 8, pp. 493-507
Closed Access | Times Cited: 122
Effect of Cigarette Smoke on Gut Microbiota: State of Knowledge
Xiaohua Gui, Zhongli Yang, Ming D. Li
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 114
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries
Zhanju Liu, Ruize Liu, Han Gao, et al.
Nature Genetics (2023) Vol. 55, Iss. 5, pp. 796-806
Open Access | Times Cited: 98
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Yameng Cao, Kai Cheng, Mei Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65
TGF-β, EMT, and resistance to anti-cancer treatment
Xuecong Wang, Pieter J.A. Eichhorn, Jean Paul Thiery
Seminars in Cancer Biology (2023) Vol. 97, pp. 1-11
Open Access | Times Cited: 53
Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases
Katarzyna Akutko, Andrzej Stawarski
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2466-2466
Open Access | Times Cited: 92
Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
Linshan Duan, Shu-Yu Cheng, Long Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 87
Dendritic cell derived exosomes loaded with immunoregulatory cargo reprogram local immune responses and inhibit degenerative bone disease in vivo
Mahmoud Elashiry, Mohamed Mohamed Elashiry, Ranya Elsayed, et al.
Journal of Extracellular Vesicles (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 84
Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses
Viviani Mendes de Almeida, Izabela Galvão, Angélica T. Vieira
Journal of Interferon & Cytokine Research (2019) Vol. 39, Iss. 7, pp. 393-409
Closed Access | Times Cited: 81
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Jie Wang, Sinan Lin, J. Mark Brown, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 211-227
Open Access | Times Cited: 77
Microplastic consumption induces inflammatory signatures in the colon and prolongs a viral arthritis
Daniel J. Rawle, Troy Dumenil, Tang Bing, et al.
The Science of The Total Environment (2021) Vol. 809, pp. 152212-152212
Open Access | Times Cited: 66
TGF-beta signal transduction: biology, function and therapy for diseases
Yan Tie, Fan Tang, Dandan Peng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 65
Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
Jitske van den Bulk, Noel F.C.C. de Miranda, Peter ten Dijke
Clinical Science (2021) Vol. 135, Iss. 1, pp. 35-52
Open Access | Times Cited: 57
Synthetic Lignin-Derived Therapeutic Nano Reagent as Intestinal pH-Sensitive Drug Carriers Capable of Bypassing the Gastric Acid Environment for Colitis Treatment
Chengke Zhao, Jiali Yang, Mingfeng Chen, et al.
ACS Nano (2022) Vol. 17, Iss. 1, pp. 811-824
Closed Access | Times Cited: 42
Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice
Yingni Lv, Mengjiao Ren, Min Yao, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122741-122741
Closed Access | Times Cited: 32
Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directions
Robert D. Little, Thisun Jayawardana, S Koentgen, et al.
eGastroenterology (2024) Vol. 2, Iss. 1, pp. e100006-e100006
Open Access | Times Cited: 10
Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease
Charles Caër, Mary Jo Wick
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 67
Current perspectives on inhibitory SMAD7 in health and disease
Charlotte de Ceuninck van Capelle, Maureen Spit, Peter ten Dijke
Critical Reviews in Biochemistry and Molecular Biology (2020) Vol. 55, Iss. 6, pp. 691-715
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top